医院市场竞争与经导管主动脉瓣置换术采用的关系
本研究利用美国5个州住院数据库2011至2014年数据,纳入5563例TAVR和30672例外科主动脉瓣置换患者,覆盖154家医院。采用赫芬达尔-赫希曼指数(HHI)划分市场竞争程度,发现高竞争医院较低竞争医院更可能采用TAVR(ORadj 5.31,95%CI 2.10-13.4),且高竞争医院患者出院回家 odds 更高(ORadj 2.39,95%CI 1.23-4.66)。竞争与院内死亡率或住院时长无关。
要点
- 高竞争医院较低竞争医院采用TAVR的调整OR为5.31(95%CI 2.10-13.4)。
- TAVR使用逐年增加(ORadj 1.73,95%CI 1.38-2.17),但各竞争类别间趋势相似。
- 高竞争医院患者出院回家ORadj为2.39(95%CI 1.23-4.66),竞争与死亡率或住院时长无关。
核心结论
- 医院市场竞争与TAVR采用呈正相关,高竞争医院更可能采用TAVR。
研究设计与样本
- 回顾性队列研究,使用5个州住院数据库(亚利桑那、佛罗里达、爱荷华、马萨诸塞、华盛顿),纳入2011至2014年154家医院的5563例TAVR和30672例外科主动脉瓣置换患者。
主要发现
- 高竞争医院较低竞争医院TAVR使用调整OR为5.31(95%CI 2.10-13.4)。
- TAVR使用逐年增加(ORadj 1.73,95%CI 1.38-2.17),但各HHI类别间相似。
- 竞争与院内死亡率或住院时长无关。
- 高竞争医院患者出院回家调整OR为2.39(95%CI 1.23-4.66)。
关键数值与推荐
- HHI低竞争为>0.25,中等竞争为0.15-0.25,高竞争为<0.15。
临床怎么用
- 临床医生在选择TAVR时需考虑医院市场竞争环境对技术采用的影响。
- 高竞争医院可能更积极采用TAVR,但需关注其质量与适宜性。
局限性
- 研究为观察性设计,仅纳入5个州数据,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of transcatheter aortic valve replacement (TAVR) has grown rapidly. The purpose of this study was to assess whether hospital market competition was associated with the use of TAVR. METHODS: We used 5 Healthcare Cost and Utilization Project state inpatient databases (Arizona, Florida, Iowa, Massachusetts, Washington) to identify patients undergoing TAVR (n = 5563) or surgical aortic valve replacement (n = 30,672) across 154 hospitals from 2011 to 2014. Using the Herfindahl-Hirschman Index (HHI) to calculate market competition, hospitals were categorized into commonly used categories of low (HHI >0.25), moderate (HHI 0.15-0.25), and high (HHI <0.15) competition. We associated market competition category with TAVR utilization using hierarchical logistic regression, adjusting for patient characteristics, hospital characteristics, year, and hospital random effect. We modeled associations between HHI category and in-hospital mortality, admission length of stay, and discharge to home as secondary outcomes. RESULTS: After adjustment, patients treated at high-competition hospitals had higher odds of receiving TAVR, relative to patients at low-competition hospitals (adjusted odds ratio [ORadj], 5.31; 95% confidence interval [CI], 2.10-13.4). TAVR use increased each year (ORadj, 1.73; 95% CI, 1.38-2.17) but was similar across HHI categories. Competition was not associated with in-hospital mortality or length of stay. Patients at high-competition hospitals were more likely to be discharged home (ORadj, 2.39; 95% CI, 1.23-4.66) compared with patients at low-competition hospitals. CONCLUSIONS: Market competition was positively associated with a hospital's adoption of TAVR. Future studies should further examine the impact of competition on quality and appropriateness.
引用
- Strobel RJ, Likosky DS, Brescia AA, et al. The Effect of Hospital Market Competition on the Adoption of Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2019. PMID: 31394089. doi:10.1016/j.athoracsur.2019.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。